Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis
Victor M. Lu, Anshit Goyal, Adrian V. Lee, et al.
Journal of Neuro-Oncology (2018) Vol. 142, Iss. 1, pp. 1-10
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
Akash J. Patel, Ying-Wooi Wan, Rami Al‐Ouran, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 43, pp. 21715-21726
Open Access | Times Cited: 155
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis
Christian Mirian, Anne Katrine Duun‐Henriksen, Tareq A. Juratli, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 4, pp. 378-387
Open Access | Times Cited: 98
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
Lisa Quetel, Clément Meiller, Jean‐Baptiste Assié, et al.
Molecular Oncology (2020) Vol. 14, Iss. 6, pp. 1207-1223
Open Access | Times Cited: 88
WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index
Alexander F. Haddad, Jacob S. Young, Ishan Kanungo, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63
Clinicopathological Correlation of TERTp (Telomerase Reverse Transcriptase Promoter) Mutation in Meningiomas
Mohammed Nadeem, Sravya Palavalasa, Manish Beniwal, et al.
Neurology India (2025) Vol. 73, Iss. 1, pp. 64-69
Closed Access
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)
Dimitrios Andreikos, Demetrios�� Spandidos, Vasiliki Georgakopoulou
International Journal of Oncology (2025) Vol. 66, Iss. 3
Closed Access
Meningioma: Novel Diagnostic and Therapeutic Approaches
Carlen Yuen, M.Y. Zheng, Max A. Saint-Germain, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 659-659
Open Access
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis
TIN MAY AUNG, Chetta Ngamjarus, Tanakorn Proungvitaya, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303337-e0303337
Open Access | Times Cited: 3
Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection
Joshua Materi, David Mampre, Jeff Ehresman, et al.
Journal of neurosurgery (2020) Vol. 134, Iss. 2, pp. 410-416
Open Access | Times Cited: 26
Pathology and Molecular Biology of Melanoma
Tanase Timis, Jón Þór Bergþorsson, Victor Greiff, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 7, pp. 5575-5597
Open Access | Times Cited: 9
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas
Adele Fioravanzo, Maria Caffo, Rina Di Bonaventura, et al.
Journal of Neuropathology & Experimental Neurology (2020) Vol. 79, Iss. 5, pp. 500-507
Open Access | Times Cited: 21
New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
Aysha Alsahlawi, Rasha Aljelaify, Amna Magrashi, et al.
Oncotarget (2019) Vol. 10, Iss. 53, pp. 5549-5559
Open Access | Times Cited: 21
Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
Ilaria Maggio, Enrico Franceschi, Vincenzo Di Nunno, et al.
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1852-1852
Open Access | Times Cited: 16
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care
S. Joy Trybula, Mark W. Youngblood, Constantine L. Karras, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1753-1753
Open Access | Times Cited: 2
Evolving concepts in meningioma management in the era of genomics
Annie L. Hsieh, Wenya Linda Bi, Vijaya Ramesh, et al.
Cancer (2024) Vol. 130, Iss. 15, pp. 2586-2600
Open Access | Times Cited: 2
Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study
Arbaz Momin, Jianning Shao, Pranay Soni, et al.
Journal of Neuro-Oncology (2021) Vol. 152, Iss. 2, pp. 373-382
Closed Access | Times Cited: 15
The Emerging Relevance of H3K27 Trimethylation Loss in Meningioma: A Systematic Review of Recurrence and Overall Survival with Meta-Analysis
Victor M. Lu, Evan Luther, Daniel G. Eichberg, et al.
World Neurosurgery (2022) Vol. 163, pp. 87-95.e1
Closed Access | Times Cited: 10
Novel lncRNA lncFAM200B: Molecular Characteristics and Effects of Genetic Variants on Promoter Activity and Cattle Body Measurement Traits
Sihuan Zhang, Zihong Kang, Xiaomei Sun, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 16
Pearls for Interpreting Neurosurgical Systematic Reviews and Meta-Analyses: Lessons From a Collaborative Effort
Victor M. Lu, Christopher S. Graffeo, Avital Perry, et al.
Neurosurgery (2020) Vol. 87, Iss. 3, pp. 435-441
Open Access | Times Cited: 16
Brain Invasion and Trends in Molecular Research on Meningioma
Kyeong-O Go, Young Zoon Kim
Brain Tumor Research and Treatment (2023) Vol. 11, Iss. 1, pp. 47-47
Open Access | Times Cited: 5
Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies
Zoltán Krabóth, Bernadette Kálmán
Pathology & Oncology Research (2019) Vol. 26, Iss. 4, pp. 2035-2047
Open Access | Times Cited: 14
Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
Orit Uziel, Andrew A. Kanner, Einat Beery, et al.
Cancer Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Regrowth factors of WHO grade I skull base meningiomas following incomplete resection
Hun Ho Park, Jihwan Yoo, Hyeong-Cheol Oh, et al.
Journal of neurosurgery (2022) Vol. 137, Iss. 6, pp. 1656-1665
Closed Access | Times Cited: 6
Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT
Louise Stögbauer, Christian Thomas, Andrea Wagner, et al.
Journal of neurosurgery (2020) Vol. 135, Iss. 3, pp. 845-854
Closed Access | Times Cited: 8
Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas
Ilah Shin, Yae Won Park, Sung Soo Ahn, et al.
Journal of Neuroradiology (2021) Vol. 49, Iss. 1, pp. 59-65
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top